There is an increased prevalence of hepatitis B due to the exploding urbanization and environmental changes due to a changing lifestyle. This situation creates a huge opportunity for hepatitis B diagnostic test manufacturers. In addition, a rising awareness due to the initiatives taken by governments and non-profit organizations is likely to fuel the growth of the global hepatitis B diagnostic test market.
As per the report figures, the North America hepatitis B diagnostic tests market was estimated to be valued at nearly US$ 140 Mn in 2017 and is expected to reach a valuation of nearly US$ 210 Mn in 2025, exhibiting a CAGR of 4.6% during the assessment period of 2017-2025.

The global Hepatitis B Diagnostic Tests market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Hepatitis B Diagnostic Tests volume and value at global level, regional level and company level. From a global perspective, this report represents overall Hepatitis B Diagnostic Tests market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Hepatitis B Diagnostic Tests in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Hepatitis B Diagnostic Tests manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
bioMerieux
Bio-Rad
DiaSorin
Abbott
Meridian Bioscience
Vista
Biogate
J.Mitra
Siemens Medical Solutions

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Enzyme Immunoassay Kits
Point-of-Care Testing Kits

Segment by Application
Hospitals
Clinics
Diagnostic Centres
Home Care